|
1) Duhrsen U, Hossfeld DK. Stromal abnormality in neoplastic bone marrow disease. Ann Hematol. 1996; 73: 53-73
|
|
|
|
2) Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70
|
|
|
|
|
|
3) Yang FC, Ingram DA, Chen S, et al. Nf1-dependent tumors require a microenvironment containing Nf1＋/-- and c-kit-dependent bone marrow. Cell. 2008; 135: 437-48
|
|
|
|
|
|
4) Trimboli AJ, Cantemir-Stone CZ, Li F, et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature. 2009; 461: 1084-91
|
|
|
|
|
|
5) Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumor vasculization via endotherial differentiation of glioblastoma stem-like cells. Nature. 2010; 468: 824-8
|
|
|
|
|
|
6) Wang R, Charadalavada K, Wilshire J, et al. Glioblastoma stem-like cells give rise to tumor endothelium. Nature. 2010; 468: 829-33
|
|
|
|
|
|
7) Soda Y, Marumoto T, Friedman-Morvinski D, et al. Transdifferentiation of glioblastoma cells into vascular endotherila cells. Proc Natl Acad Sci U S A. 2011; 108: 4274-80
|
|
|
|
|
|
8) Ramakrishnan A, Deeg HJ. A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease. Expert Opin Biol Ther. 2009; 9: 21-8
|
|
|
|
|
|
9) Bhatia R, McGlave PB, Dewald GW, et al. Abnormal function of bone marrow micro-environment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood. 1995; 85: 3636-45
|
|
|
|
|
|
10) Schmidt T, Masouleh BK, Logas S, et al. Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1＋ leukemia. Cancer Cell. 2011; 19: 740-53
|
|
|
|
|
|
11) Lawler M, Locasciulli A, Longoni D, et al. Leukemic transformation of donor cells in a patient receiving a second allogenic bone marrow transplant for severe aplastic anemia. Bone Marrow Transplant. 2002; 29: 453-6
|
|
|
|
|
|
12) Mc Cann SR, Lawler M, Gardinar N, et al. Stroma-mediated dysregulation of myelopoiesis in mice lacking IκBα. Immunity. 2005; 22: 479-91
|
|
|
|
|
|
13) Walkely CR, Shea JM, Sims NA, et al. Rb regulates interactions between hematopoietic stem cells and their bone marrow micro-environment. Cell. 2007; 129: 1181-95
|
|
|
|
|
|
14) Walkely CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptorγ deficiency. Cell. 2007; 129: 1097-110
|
|
|
|
|
|
15) Raajimakers MHGP, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelo-dysplasia and secondary leukemia. Nature. 2010; 464: 852-7
|
|
|
|
|
|
16) Dror Y, Freedman MH. Shwachman-Diamond syndrome: an inherited preleukemix bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood. 1999; 94: 3048-54
|
|
|
|
|
|
17) Rawls S, Gregory AD, Woloszynek JR, et al. Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential. Blood. 2007; 110: 2414-22
|
|
|
|
|